Company / Free Cash Flow per Share
PLUS THERAPEUTICS, INC. Free Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.81
FY2025
5-year range
-$2.93 / -$0.10
FY2021-FY2025
Trend
+38.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-2.93 in FY2024 to $-0.10 in FY2017.
Based on SEC 10-K filings.
-1.81 in FY2025.
Declined from $-0.10 to $-1.81 over the past 8 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 38.0% year-over-year.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.81 | +38.0% |
| FY2024 | -$2.93 | - |
| FY2018 | - | - |
| FY2017 | -$0.10 | +94.0% |
| FY2016 | -$1.62 | -359.0% |
| FY2015 | -$0.35 | +24.6% |
| FY2014 | -$0.47 | +14.0% |
| FY2013 | -$0.54 | -27.4% |
| FY2012 | -$0.43 | +7.6% |
| FY2011 | -$0.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026